Dysbiosis refers to an imbalance in the composition of the microbiota, which can lead to immune system dysfunction and disease. The mammalian immune system develops through interactions with resident commensal microorganisms. Abnormal immune responses to environmental and self-antigens are associated with diseases such as inflammatory bowel disease (IBD), multiple sclerosis (MS), type I diabetes (T1D), allergies, and asthma. Dysbiosis is defined as any change in the microbial community structure relative to a healthy individual. It can manifest in three main forms: loss of beneficial microbes, expansion of pathobionts (potentially harmful microbes), and reduced microbial diversity. These changes can disrupt the immune system's ability to maintain homeostasis, leading to disease. The microbiota plays a crucial role in immune development and homeostasis. For example, beneficial microbes like Bacteroides fragilis and Clostridium species help regulate immune responses by promoting the development of regulatory T cells (Tregs), which suppress inflammation and autoimmunity. Tregs are essential for maintaining tolerance to self-tissues and commensals. Dysbiosis can impair Treg function, leading to immune-mediated diseases. Additionally, certain commensal bacteria can directly reduce inflammation by degrading inflammatory cytokines, such as IP-10. Pathobionts, which are typically kept in low numbers in a healthy gut, can cause disease when their numbers increase. For example, Proteobacteria, particularly members of the Enterobacteriaceae family, have been linked to colitis in mouse models. These bacteria can penetrate the intestinal mucosa and cause inflammation. Similarly, fungal species like Candida albicans can overgrow in the gut following antibiotic treatment, leading to increased susceptibility to diseases. Loss of microbial diversity is also a key aspect of dysbiosis. A diverse microbiota is essential for maintaining immune homeostasis, as different microbes contribute to various aspects of host health. Studies have shown that a diverse microbiota can enhance the development of regulatory T cells and suppress allergic responses. However, reduced diversity can lead to increased susceptibility to diseases. Rebiosis, the process of restoring a healthy microbiota, is an emerging therapeutic approach. Fecal microbiota transplantation (FMT) has shown promise in treating conditions like Clostridium difficile infection. Other strategies, such as probiotics and prebiotics, are being explored to restore microbial balance. Understanding the mechanisms by which the microbiota influences host health is crucial for developing effective therapies for immune-related diseases.Dysbiosis refers to an imbalance in the composition of the microbiota, which can lead to immune system dysfunction and disease. The mammalian immune system develops through interactions with resident commensal microorganisms. Abnormal immune responses to environmental and self-antigens are associated with diseases such as inflammatory bowel disease (IBD), multiple sclerosis (MS), type I diabetes (T1D), allergies, and asthma. Dysbiosis is defined as any change in the microbial community structure relative to a healthy individual. It can manifest in three main forms: loss of beneficial microbes, expansion of pathobionts (potentially harmful microbes), and reduced microbial diversity. These changes can disrupt the immune system's ability to maintain homeostasis, leading to disease. The microbiota plays a crucial role in immune development and homeostasis. For example, beneficial microbes like Bacteroides fragilis and Clostridium species help regulate immune responses by promoting the development of regulatory T cells (Tregs), which suppress inflammation and autoimmunity. Tregs are essential for maintaining tolerance to self-tissues and commensals. Dysbiosis can impair Treg function, leading to immune-mediated diseases. Additionally, certain commensal bacteria can directly reduce inflammation by degrading inflammatory cytokines, such as IP-10. Pathobionts, which are typically kept in low numbers in a healthy gut, can cause disease when their numbers increase. For example, Proteobacteria, particularly members of the Enterobacteriaceae family, have been linked to colitis in mouse models. These bacteria can penetrate the intestinal mucosa and cause inflammation. Similarly, fungal species like Candida albicans can overgrow in the gut following antibiotic treatment, leading to increased susceptibility to diseases. Loss of microbial diversity is also a key aspect of dysbiosis. A diverse microbiota is essential for maintaining immune homeostasis, as different microbes contribute to various aspects of host health. Studies have shown that a diverse microbiota can enhance the development of regulatory T cells and suppress allergic responses. However, reduced diversity can lead to increased susceptibility to diseases. Rebiosis, the process of restoring a healthy microbiota, is an emerging therapeutic approach. Fecal microbiota transplantation (FMT) has shown promise in treating conditions like Clostridium difficile infection. Other strategies, such as probiotics and prebiotics, are being explored to restore microbial balance. Understanding the mechanisms by which the microbiota influences host health is crucial for developing effective therapies for immune-related diseases.